Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001755876-22-000001
Filing Date
2022-02-01
Accepted
2022-02-01 15:37:46
Documents
1
Effectiveness Date
2022-02-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5691
  Complete submission text file 0001755876-22-000001.txt   6768
Mailing Address 485 MASSACHUSETTS AVENUE SUITE 324 CAMBRIDGE MA 02139
Business Address 485 MASSACHUSETTS AVENUE SUITE 324 CAMBRIDGE MA 02139 8575297776
Epicore Biosystems, Inc. (Filer) CIK: 0001755876 (see all company filings)

EIN.: 821356381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-419663 | Film No.: 22578665